ASLAN Pharmaceuticals Limited [NASDAQ: ASLN] shares went higher by 384.20% from its previous closing of $0.44, now trading at the price of $2.13, also adding 1.69 points. Is ASLN stock a buy or should you stay away?
The stock had a rather active trading session with the latest closing, by far recording 6.69 million contracts. Compared to the average trading volume of ASLN shares, the company saw a far better performance. Moreover, the stock has a 28.15M float and a +402.23% run over in the last seven days. ASLN share price has been hovering between $6.48 and $0.35 lately, and is definitely worthy of attention.
ASLAN Pharmaceuticals Limited [NASDAQ:ASLN]: Analyst Rating and Earnings
Its stock price has been found in the range of 0.35 to 6.48. This is compared to its latest closing price of $0.44.
Stay on the lookout for the next quarterly financial report – the company is expected to release the following results on Thu 31 Oct (22 days ago).
Fundamental Analysis of ASLAN Pharmaceuticals Limited [ASLN]
Turning to investigate this organization’s capital structure, ASLAN Pharmaceuticals Limited [ASLN] has generated a Total Debt to Total Equity ratio of 36.99. Similarly, its Total Debt to Total Capital is 27.00, while its Total Debt to Total Assets stands at 21.42. Looking toward the future, this publicly-traded company’s Long-Term Debt to Equity is -86.09, and its Long-Term Debt to Total Capital is 36.99.
What about valuation? This company’s Enterprise Value to EBITDA is -0.40. The Enterprise Value to Sales for this firm is now 5.48, and its Total Debt to Enterprise Value stands at 0.11. ASLAN Pharmaceuticals Limited [ASLN] has a Price to Book Ratio of 4.32.
This publicly-traded organization’s liquidity data is also interesting: its Quick Ratio is 3.64 and its Current Ratio is 3.64. This company, considering these metrics, has a healthy ratio between its short-term liquid assets and its short-term liabilities, making it a less risky investment.
ASLAN Pharmaceuticals Limited [ASLN] has 32.05M shares outstanding, amounting to a total market cap of $14.10M. Its stock price has been found in the range of 0.35 to 6.48. At its current price, it has moved down by -67.13% from its 52-week high, and it has moved up 508.57% from its 52-week low.
This stock’s Relative Strength Index (RSI) is at 65.03. This RSI score is good, suggesting this stock is neither overbought or oversold.
Conclusion: Is ASLAN Pharmaceuticals Limited [ASLN] a Reliable Buy?
Shares of ASLAN Pharmaceuticals Limited [ASLN], on the whole, present investors with both positive and negative signals. Wall Street analysts have mixed reviews when it comes to the 12-month price outlook, and this company’s financials show a combination of strengths and weaknesses. Based on the price performance, this investment is somewhat risky while presenting reasonable potential for ROI.